DAVIS STEPHEN
Insider CIK 1131146 · ACAD President and CEO, Director · RDEA EVP & COO · BLCM Director · FURX Director · APPA Chief Operating Officer, Director · GEVA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2024-08-19 | 2024-08-20 | 31,747 | $15.28 | $485.1K | 186,555 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award | 2024-08-16 | 2024-08-20 | 17,333 | — | $0 | 173,520 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award | 2024-08-16 | 2024-08-20 | 44,782 | — | $0 | 218,302 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2024-05-02 | 2024-05-03 | 11,427 | $16.94 | $193.6K | 155,231 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2024-05-01 | 2024-05-03 | 22,391 | — | $0 | 67,173 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2024-05-01 | 2024-05-03 | 22,391 | — | $0 | 166,658 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2024-04-08 | 2024-04-09 | 8,858 | $17.87 | $158.3K | 161,983 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2024-04-08 | 2024-04-09 | 17,716 | $17.87 | $316.6K | 144,267 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2024-04-05 | 2024-04-09 | 34,666 | — | $0 | 138,666 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2024-04-05 | 2024-04-09 | 17,333 | — | $0 | 34,667 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2024-04-05 | 2024-04-09 | 34,666 | — | $0 | 170,841 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2024-04-05 | 2024-04-09 | 17,333 | — | $0 | 136,175 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2024-03-27 | 2024-03-27 | 17,714 | $17.90 | $317.1K | 118,842 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2024-03-25 | 2024-03-27 | 286,451 | — | $0 | 286,451 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award | 2024-03-25 | 2024-03-27 | 34,666 | — | $0 | 136,556 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2024-02-26 | 2024-02-27 | 5,577 | $24.67 | $137.6K | 101,890 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2024-02-23 | 2024-02-27 | 10,946 | — | $0 | 10,946 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2024-02-23 | 2024-02-27 | 10,946 | — | $0 | 107,467 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2024-01-08 | 2024-01-09 | 3,732 | $29.96 | $111.8K | 96,521 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2024-01-06 | 2024-01-09 | 9,528 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2024-01-06 | 2024-01-09 | 9,528 | — | $0 | 100,253 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2023-10-06 | 2023-10-06 | 103,999 | — | $0 | 173,332 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2023-10-06 | 2023-10-06 | 51,563 | $21.96 | $1.13M | 89,131 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2023-10-05 | 2023-10-06 | 103,999 | — | $0 | 140,694 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2023-07-14 | 2023-07-18 | 100,000 | — | $0 | 220,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2023-07-14 | 2023-07-18 | 100,000 | $20.77 | $2.08M | 136,695 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2023-07-14 | 2023-07-18 | 100,000 | $30.04 | $3.00M | 36,695 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2023-07-12 | 2023-07-13 | 55,104 | $25.05 | $1.38M | 36,695 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2023-07-11 | 2023-07-13 | 16,498 | $25.00 | $412.4K | 91,799 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2023-05-01 | 2023-05-03 | 89,564 | — | $0 | 89,564 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2023-05-01 | 2023-05-03 | 295,503 | — | $0 | 295,503 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2023-05-01 | 2023-05-02 | 7,806 | $21.18 | $165.3K | 108,297 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2023-04-29 | 2023-05-02 | 15,625 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2023-04-29 | 2023-05-02 | 15,625 | — | $0 | 116,103 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2023-04-06 | 2023-04-07 | 8,582 | $18.16 | $155.8K | 100,478 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2023-04-05 | 2023-04-07 | 17,333 | — | $0 | 52,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2023-04-05 | 2023-04-07 | 17,333 | — | $0 | 109,060 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2023-02-24 | 2023-02-27 | 3,851 | $18.78 | $72.3K | 91,727 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2023-02-23 | 2023-02-27 | 10,945 | — | $0 | 21,892 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2023-02-23 | 2023-02-27 | 10,945 | — | $0 | 95,578 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2023-01-09 | 2023-01-10 | 3,904 | $17.13 | $66.9K | 84,633 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2023-01-06 | 2023-01-10 | 9,528 | — | $0 | 9,528 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2023-01-06 | 2023-01-10 | 9,528 | — | $0 | 88,537 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise | 2023-01-03 | 2023-01-05 | 74,739 | — | $0 | 136,854 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2022-12-16 | 2022-12-20 | 77,160 | — | $0 | 77,160 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award | 2022-12-16 | 2022-12-20 | 38,580 | — | $0 | 52,032 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2022-10-15 | 2022-10-18 | 5,938 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2022-10-15 | 2022-10-18 | 5,938 | — | $0 | 81,813 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2022-10-15 | 2022-10-18 | 2,804 | $15.81 | $44.3K | 79,009 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise | 2022-09-01 | 2022-09-02 | 43,400 | — | $0 | 62,115 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2022-06-15 | 2022-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2022-05-02 | 2022-05-03 | 5,483 | $18.18 | $99.7K | 75,875 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2022-04-29 | 2022-05-03 | 15,625 | — | $0 | 15,625 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2022-04-29 | 2022-05-03 | 15,625 | — | $0 | 81,358 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2022-04-05 | 2022-04-07 | 237,931 | — | $0 | 237,931 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2022-04-05 | 2022-04-07 | 69,333 | — | $0 | 69,333 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2022-04-05 | 2022-04-07 | 277,331 | — | $0 | 277,331 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2022-02-23 | 2022-02-25 | 10,945 | — | $0 | 32,837 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2022-02-23 | 2022-02-25 | 3,928 | $23.80 | $93.5K | 65,733 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2022-02-23 | 2022-02-25 | 10,945 | — | $0 | 69,661 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2022-01-06 | 2022-01-10 | 9,527 | — | $0 | 19,056 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2022-01-06 | 2022-01-10 | 3,718 | $23.05 | $85.7K | 58,716 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2022-01-06 | 2022-01-10 | 9,527 | — | $0 | 62,434 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise deriv | 2022-01-04 | 2022-01-06 | 18,715 | — | $0 | 0 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise | 2022-01-04 | 2022-01-06 | 18,715 | — | $0 | 18,715 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2021-12-22 | 2021-12-23 | 20,903 | — | $0 | 20,903 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award | 2021-12-22 | 2021-12-23 | 10,452 | — | $0 | 13,452 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2021-10-18 | 2021-10-19 | 2,963 | $17.41 | $51.6K | 52,906 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2021-10-15 | 2021-10-19 | 5,938 | — | $0 | 5,938 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2021-10-15 | 2021-10-19 | 5,938 | — | $0 | 55,869 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2021-06-15 | 2021-07-07 | 6,500 | — | $0 | 6,500 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2021-04-30 | 2021-04-30 | 7,850 | $20.33 | $159.6K | 49,312 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2021-04-29 | 2021-04-30 | 15,625 | — | $0 | 31,250 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2021-04-29 | 2021-04-30 | 15,625 | — | $0 | 57,162 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2021-02-23 | 2021-02-25 | 161,230 | — | $0 | 161,230 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2021-02-23 | 2021-02-25 | 43,782 | — | $0 | 43,782 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2021-02-04 | 2021-02-08 | 40,625 | — | $0 | 40,625 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2021-02-04 | 2021-02-08 | 40,625 | — | $0 | 40,625 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2021-02-04 | 2021-02-08 | 23,750 | — | $0 | 23,750 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2021-02-04 | 2021-02-08 | 14,195 | $50.61 | $718.4K | 28,900 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award | 2021-02-04 | 2021-02-08 | 31,250 | — | $0 | 43,059 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2021-01-06 | 2021-01-08 | 9,527 | — | $0 | 28,583 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2021-01-06 | 2021-01-08 | 9,527 | — | $0 | 27,966 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2021-01-06 | 2021-01-08 | 3,484 | $53.34 | $185.8K | 24,482 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2021-01-04 | 2021-01-05 | 18,715 | — | $0 | 18,715 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2020-12-21 | 2020-12-23 | 18,000 | — | $0 | 18,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award | 2020-12-21 | 2020-12-23 | 3,000 | — | $0 | 3,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2020-10-16 | 2020-10-19 | 2,960 | $42.56 | $126.0K | 14,786 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2020-10-15 | 2020-10-19 | 5,937 | — | $0 | 11,876 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2020-10-15 | 2020-10-19 | 5,937 | — | $0 | 17,746 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2020-10-13 | 2020-10-15 | 765 | — | $0 | 765 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2020-06-15 | 2020-06-16 | 6,500 | — | $0 | 6,500 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2020-05-14 | 2020-05-15 | 88,542 | — | $0 | 100,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2020-05-14 | 2020-05-15 | 4,321 | $45.01 | $194.5K | 11,809 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2020-05-14 | 2020-05-15 | 88,542 | $19.65 | $1.74M | 100,351 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2020-05-14 | 2020-05-15 | 84,221 | $45.65 | $3.84M | 16,130 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2020-05-13 | 2020-05-15 | 111,458 | — | $0 | 188,542 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2020-05-13 | 2020-05-15 | 63,392 | $45.71 | $2.90M | 20,006 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2020-05-13 | 2020-05-15 | 20,756 | $46.43 | $963.7K | 83,398 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2020-05-13 | 2020-05-15 | 13,908 | $48.98 | $681.2K | 109,359 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2020-05-13 | 2020-05-15 | 111,458 | $19.65 | $2.19M | 123,267 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2020-05-13 | 2020-05-15 | 8,197 | $45.12 | $369.8K | 11,809 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2020-05-13 | 2020-05-15 | 5,205 | $48.60 | $253.0K | 104,154 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2020-04-30 | 2020-05-01 | 6,770 | $49.21 | $333.2K | 11,809 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2020-04-29 | 2020-05-01 | 15,625 | — | $0 | 46,875 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2020-04-29 | 2020-05-01 | 15,625 | — | $0 | 18,579 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2020-04-15 | 2020-04-17 | 1,426 | — | $0 | 1,426 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2020-01-06 | 2020-01-08 | 138,304 | — | $0 | 138,304 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2020-01-06 | 2020-01-08 | 38,110 | — | $0 | 38,110 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2019-12-19 | 2019-12-23 | 15,500 | — | $0 | 15,500 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2019-12-05 | 2019-12-06 | 150,000 | — | $0 | 300,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2019-12-05 | 2019-12-06 | 150,000 | $19.65 | $2.95M | 152,954 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2019-12-05 | 2019-12-06 | 81,585 | $52.82 | $4.31M | 71,369 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2019-12-05 | 2019-12-06 | 40,159 | $52.09 | $2.09M | 31,210 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2019-12-05 | 2019-12-06 | 28,256 | $51.32 | $1.45M | 2,954 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2019-10-15 | 2019-10-17 | 5,937 | — | $0 | 17,813 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2019-10-15 | 2019-10-17 | 5,937 | — | $0 | 5,937 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2019-10-15 | 2019-10-17 | 2,983 | $39.65 | $118.3K | 2,954 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2019-10-10 | 2019-10-11 | 120,208 | — | $0 | 450,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2019-10-10 | 2019-10-11 | 120,208 | $19.65 | $2.36M | 120,208 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2019-10-10 | 2019-10-11 | 120,208 | $40.19 | $4.83M | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2019-10-09 | 2019-10-11 | 29,792 | — | $0 | 570,208 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2019-10-09 | 2019-10-11 | 29,792 | $40.00 | $1.19M | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2019-10-09 | 2019-10-11 | 29,792 | $19.65 | $585.4K | 29,792 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2019-10-01 | 2019-10-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2019-10-01 | 2019-10-01 | 750 | — | $0 | 750 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2019-06-13 | 2019-06-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2019-04-29 | 2019-05-01 | 62,500 | — | $0 | 62,500 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2019-04-29 | 2019-05-01 | 219,298 | — | $0 | 219,298 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2018-10-15 | 2018-10-24 | 23,750 | — | $0 | 23,750 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2018-10-15 | 2018-10-24 | 95,000 | — | $0 | 95,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2018-06-14 | 2018-06-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2018-04-18 | 2018-04-20 | 135,000 | — | $0 | 135,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2017-09-07 | 2017-09-08 | 243,750 | — | $0 | 243,750 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2017-06-14 | 2017-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2017-03-08 | 2017-03-10 | 243,750 | — | $0 | 243,750 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2016-06-15 | 2016-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2016-03-15 | 2016-03-17 | 600,000 | — | $0 | 600,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2015-09-01 | 2015-09-03 | 225,000 | — | $0 | 225,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2015-07-13 | 2015-07-15 | 9,167 | — | $0 | 9,167 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2015-07-13 | 2015-07-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 4,000 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 7,500 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 7,500 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 3,000 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 7,500 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 15,000 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 3,000 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 3,000 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 3,000 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2015-03-20 | 2015-03-24 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2015-03-20 | 2015-03-24 | 120,000 | — | $0 | 120,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2014-12-12 | 2014-12-15 | 12,500 | — | $0 | 12,500 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2014-09-26 | 2014-09-30 | 120,313 | — | $0 | 0 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2014-09-26 | 2014-09-30 | 102,634 | $8.44 | $866.2K | 20,076 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2014-09-26 | 2014-09-30 | 120,313 | $7.20 | $866.3K | 122,710 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2014-09-03 | 2014-09-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2014-07-15 | 2014-07-16 | 320,000 | — | $0 | 320,000 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | D To issuer | 2014-07-02 | 2014-07-07 | 9,308 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2014-06-04 | 2014-06-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | A Award | 2014-02-28 | 2014-03-04 | 3,580 | — | $0 | 9,308 | SEC↗ |
| APPA AP PHARMA INC /DE/ | A Award deriv | 2014-01-03 | 2014-01-07 | 1,066,667 | — | $0 | 1,066,667 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2013-06-06 | 2013-06-10 | 7,500 | — | $0 | 7,500 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | A Award | 2013-05-24 | 2013-05-29 | 5,728 | — | $0 | 5,728 | SEC↗ |
| APPA AP PHARMA INC /DE/ | A Award deriv | 2013-05-01 | 2013-05-03 | 11,000,000 | — | $0 | 11,000,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2012-06-27 | 2012-06-29 | 7,500 | — | $0 | 7,500 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 80,000 | $8.34 | $667.2K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 74,721 | $13.06 | $975.9K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 5,279 | $13.06 | $68.9K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 11,459 | $32.00 | $366.7K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 131,268 | $10.65 | $1.40M | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 18,732 | $10.65 | $199.5K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer | 2012-06-19 | 2012-06-20 | 16,099 | $32.00 | $515.2K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | F Tax w/h | 2012-06-06 | 2012-06-08 | 191 | $31.96 | $6.1K | 15,816 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | F Tax w/h | 2012-05-06 | 2012-05-07 | 191 | $31.70 | $6.1K | 15,409 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | F Tax w/h | 2012-04-06 | 2012-04-06 | 191 | $21.92 | $4.2K | 15,600 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | F Tax w/h | 2012-03-06 | 2012-03-07 | 213 | $20.33 | $4.3K | 15,791 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | F Tax w/h | 2012-02-06 | 2012-02-08 | 218 | $20.20 | $4.4K | 16,004 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | F Tax w/h | 2012-01-06 | 2012-01-06 | 218 | $15.55 | $3.4K | 16,922 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | S Sale | 2012-01-06 | 2012-01-06 | 700 | $15.91 | $11.1K | 16,222 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2011-12-20 | 2012-01-11 | 15,000 | — | $0 | 15,000 | SEC↗ |